According to our (Global Info Research) latest study, the global Heart Defect Closure Devices market size was valued at US$ 1262 million in 2025 and is forecast to a readjusted size of US$ 2253 million by 2032 with a CAGR of 8.7% during review period.
Heart Defect Closure Devices are advanced medical implants designed for catheter-based or minimally invasive surgical repair of structural cardiac defects, including atrial and ventricular septal defects, patent ductus arteriosus, and patent foramen ovale. Typically constructed from shape-memory, superelastic nitinol frames combined with fabric or membrane coverings that promote endothelialization, these devices are delivered precisely to the defect site via vascular access to provide immediate mechanical closure and long-term tissue integration. Advances in interventional imaging, navigation systems, and bioresorbable materials are driving devices toward smaller profiles, improved radiographic visibility, and enhanced biocompatibility—positioning them as key technologies for reducing hospitalization time, lowering perioperative risk, and expanding non-surgical treatment options.In 2024, global Heart Defect Closure Devices production reached approximately 388 k units, with an average global market price of around US$ 2900 perunit.The average gross profit margin of this product is 75%.
The global healthcare sector is increasingly favoring minimally invasive cardiovascular therapies, and hospitals are allocating policy and operational resources toward catheter-based repair pathways, accelerating the routine adoption of closure devices in both pediatric and adult structural heart disease. Technical advances by industry leaders in device miniaturization and novel materials are expanding clinical indications and improving access, creating long-term opportunities to substitute traditional surgical approaches.
Despite promising prospects, regulatory review and long-term post-market surveillance remain stringent, particularly regarding long-term safety and complication monitoring. Post-implant thrombosis, arrhythmia, and incomplete closure present clinical risks that demand higher design and quality standards. Regional differences in healthcare infrastructure and reimbursement further add uncertainty to market entry and commercialization. Regulatory emphasis on post-approval studies also raises the bar for R&D and clinical strategies.
Clinicians increasingly seek devices with improved conformability, imaging visibility, and anatomy-matched, patient-specific solutions, while demand for adult structural and complex defect interventions is growing. At the same time, improvements in local supply chains and training across regions are intensifying competition between domestic and multinational players, shifting competitive advantage from single-technology leadership toward comprehensive service and ecosystem capabilities.
The device performance hinges on medical-grade nitinol and functional covering materials; their quality directly influences mechanical behavior and biocompatibility. Upstream supply is consolidating around suppliers with strict traceability and medical certifications, and material innovations (e.g., bioresorbable polymers, modified PTFE/PET) are becoming key differentiation levers. Supply-chain integration and rigorous quality control will remain critical entry barriers and determinants of manufacturing cost and time-to-market.
This report is a detailed and comprehensive analysis for global Heart Defect Closure Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Heart Defect Closure Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Heart Defect Closure Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Heart Defect Closure Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Heart Defect Closure Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heart Defect Closure Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Heart Defect Closure Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Heart Defect Closure Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Market segment by Device Structure
Double Disc Devices
Single Disc Devices
lug Type Devices
Market segment by Material
Nitinol
Stainless Steel
Other
Market segment by Application
Hospitals
Clinics
Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
HeartCare
Bairen Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heart Defect Closure Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heart Defect Closure Devices, with price, sales quantity, revenue, and global market share of Heart Defect Closure Devices from 2021 to 2026.
Chapter 3, the Heart Defect Closure Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heart Defect Closure Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Heart Defect Closure Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heart Defect Closure Devices.
Chapter 14 and 15, to describe Heart Defect Closure Devices sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Heart Defect Closure Devices. Industry analysis & Market Report on Heart Defect Closure Devices is a syndicated market report, published as Global Heart Defect Closure Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Heart Defect Closure Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.